Sentences with phrase «years share prices change»

Individual share prices move up and down during the day, and over days, weeks and years share prices change by a significant amount.

Not exact matches

The share prices of big entertainment companies have been extremely volatile over the past year as investors try to assess the winners and losers in the changing video ecosystem.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Net losses on securities of $ 4.3 million this year primarily reflect active risk management in view of macroeconomic conditions and changes in the pricing and liquidity of the Canadian preferred share market.

Following years of operational stagnation, substandard share price performance and all but negligible change to key oversight functions, Ultratech now faces a contested campaign led by Neuberger Berman LLC, a well - known, but generally passive investment manager.

The Services / Technology table presents 10 of the leading mining services and technology companies on the ASX, listing the latest market cap, and one - day, one - week and one - year percentage change in share prices.

The Services / Technology table presents 10 of the world's leading mining services and technology companies, listing the latest market cap, and one - day, one - week and one - year percentage change in share prices.

Over the same period, 10 - year UK government bond prices have risen nearly 6 percent while the FTSE 100 Index of blue - chip shares is little changed, at 6278.

When the pair studied the share prices of oil companies and alternative - energy technology companies, and estimated the rate of change of future investment, they found that investors do not expect the replacement of oil - based fuels with renewables for another 131 years.

In this consolidation process, one of the issues I am wrestling with is what to do with money market funds, given that later this year unless something changes again, they will be allowed to «break the buck» or no longer have a constant $ 1 share price.

Keegan Toci from BlackRock, Dave LaValle from State Street Global Advisors and Eric Pollackov from Invesco PowerShares shared their insight and expertise as to what changes and improvements have been made over the last few years to accommodate this growth and ensure orderly pricing, trading, and liquidity.

When I say «trailing 1 - year return,» basically what this means is that for any date you look up (say June 23, 2013), it will give you to price change in Berkshire Hathaway Class A Shares over the past year (in this case, since June 23, 2012).

The share price change yielded a 2.3 % per year annual return.

The major changes since my 2012 valuation have been the revaluation of the Handy & Harman share price, the ModusLink investment and my revaluation of the value of the Webank subsidiary based on the last two years of operating results.

Despite that, I've been surprised to see the share price continue its decline in the past few months... because 2012 was a game - changing year!

The share price has not really changed over the past year, and probably won't until more of the asset conversion process is complete.

It's safe to assume that the price per share will change month by month, or year by year.

NB: Year - end 2015 share price for VOF: LN re-denominated to GBP, to reflect an end - March listing currency change.

NB: Year - end VOF: LN share price converted to GBP (at year - end GBP / USD FX rate), reflecting its end - March listing change from USD to Year - end VOF: LN share price converted to GBP (at year - end GBP / USD FX rate), reflecting its end - March listing change from USD to year - end GBP / USD FX rate), reflecting its end - March listing change from USD to GBP.

(10) Total return was calculated by dividing the net change in the share price, during the year, plus the dividends paid per share, during the year, by the closing share price on December 31 or the last trading day of the preceding year

The share price of each of these has declined quite a lot over the past week, a trend that (again, selfishly) I hope continues so that I can gradually invest over the next months and years and earn a decent yield for a change with less principal risk, thanks to the Trump Thump.

Here's one potential 5 year share price trajectory: Assume an immediate tender offer (at say, a 30 % premium), with all subsequent free cash flow utilised for ongoing share buybacks, and no change in the current 0.6 P / S multiple:

On a more positive note: A few days ago the CEO apparently changed his compensation for the year from cash to shares (priced as of june 25th).

«Course, there's plenty of water under the bridge since (& fair value estimates obviously change), but I anticipated a substantial UDG price decline back in 2014... in reality, the shares almost doubled in the last few years!

In both scenarios, note I assume zero change in revenue / free cash flow over the entire period... which makes a possible multi-bagger return in just 5 years from a EUR 0.43 (or even a EUR 0.67) share price all the more astonishing!

Take a look at the chart below which shows my model portfolio «s rolling one - year total return (share price change plus dividends) relative to a FTSE All - Share index trashare price change plus dividends) relative to a FTSE All - Share index traShare index tracker:

Tapping a stock will bring you to a screen where you can see the price changes over the last five years, buttons to buy and sell, and detailed information on your currently held shares, more headlines, stats on the stock, and a history of your purchases.

In a note, Nomura Securities analyst Rick Sherlund wrote that he expects Microsoft CEO Satya Nadella to make «bold moves and organizational changes» and upped his target per share price to $ 50, from $ 45, for the year.